Evidence map›Paper›PMID 33563599›Full record

ArticleJournal of clinical microbiology2021

Evaluating Specimen Quality and Results from a Community-Wide, Home-Based Respiratory Surveillance Study.

Ashley E Kim, Elisabeth Brandstetter, Naomi Wilcox, Jessica Heimonen, Chelsey Graham, Peter D Han, Lea M Starita, Denise J McCulloch, Amanda M Casto, Deborah A Nickerson and 15 more

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Critical lessons from a pragmatic randomized trial of home-based COVID-19 testing in rural Native American and Latino communities.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2024
    Trial
  2. Article
  3. Article
  4. Article
  5. Household Transmission and Genomic Diversity of Respiratory Syncytial Virus in the United States, 2022-2023.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Innovations in public health surveillance: An overview of novel use of data and analytic methods.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Frontiers in pediatrics · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Ashley E KimDepartment of Medicine, University of Washington, Seattle, Washington, USA ashleyek@uw.edu helenchu@uw.edu.ORCID 0000-0002-0247-1346
Elisabeth BrandstetterDepartment of Medicine, University of Washington, Seattle, Washington, USA.
Naomi WilcoxDepartment of Medicine, University of Washington, Seattle, Washington, USA.
Jessica HeimonenDepartment of Medicine, University of Washington, Seattle, Washington, USA.
Chelsey GrahamBrotman Baty Institute for Precision Medicine, Seattle, Washington, USA.
Peter D HanBrotman Baty Institute for Precision Medicine, Seattle, Washington, USA.
Lea M StaritaBrotman Baty Institute for Precision Medicine, Seattle, Washington, USA.ORCID 0000-0003-2870-5099
Denise J McCullochDepartment of Medicine, University of Washington, Seattle, Washington, USA.
Amanda M CastoDepartment of Medicine, University of Washington, Seattle, Washington, USA.
Deborah A NickersonBrotman Baty Institute for Precision Medicine, Seattle, Washington, USA.
Margaret M Van de LooFormative, Seattle, Washington, USA.
Jennifer MooneyFormative, Seattle, Washington, USA.
Misja IlcisinVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Kairsten A FayVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Jover LeeVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Thomas R SibleyVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Victoria LyonDepartment of Family Medicine, University of Washington, Seattle, Washington, USA.
Rachel E GeyerDepartment of Family Medicine, University of Washington, Seattle, Washington, USA.
Matthew ThompsonDepartment of Family Medicine, University of Washington, Seattle, Washington, USA.
Barry R LutzDepartment of Family Medicine, University of Washington, Seattle, Washington, USA.
Mark J RiederBrotman Baty Institute for Precision Medicine, Seattle, Washington, USA.
Trevor BedfordBrotman Baty Institute for Precision Medicine, Seattle, Washington, USA.
Michael BoeckhVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Janet A EnglundSeattle Children's Research Institute, Seattle, Washington, USA.
Helen Y ChuDepartment of Medicine, University of Washington, Seattle, Washington, USA ashleyek@uw.edu helenchu@uw.edu.

Funding

HOST DEFENSE TRAINING IN ALLERGY AND INFECTIOUS DISEASEST32AI007044 · NIAID · UNIVERSITY OF WASHINGTON · PI DAVID Neal FREDRICKS · 1985 to 2026
$14.6M
NIAID NIH HHS T32 AI007044
6 · The paper itself

Abstract

While influenza and other respiratory pathogens cause significant morbidity and mortality, the community-based burden of these infections remains incompletely understood. The development of novel methods to detect respiratory infections is essential for mitigating epidemics and developing pandemic-preparedness infrastructure. From October 2019 to March 2020, we conducted a home-based cross-sectional study in the greater Seattle, WA, area, utilizing electronic consent and data collection instruments. Participants received nasal swab collection kits via rapid delivery within 24 hours of self-reporting respiratory symptoms. Samples were returned to the laboratory and were screened for 26 respiratory pathogens and a housekeeping gene. Participant data were recorded via online survey at the time of sample collection and 1 week later. Of the 4,572 consented participants, 4,359 (95.3%) received a home swab kit and 3,648 (83.7%) returned a nasal specimen for respiratory pathogen screening. The 3,638 testable samples had a mean RNase P relative cycle threshold (

Indexed as

Influenza, HumanRespiratory Tract InfectionsCross-Sectional StudiesHumansPandemicsSpecimen Handlinginfluenzanasal swabpandemic preparednessrapid diagnosisrespiratory pathogens

Identifiers

PMID33563599
PMCPMC8091861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.